Clinical Trial Update: 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and high-risk myelodysp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• 5-Azacytidine (5-azacytidine)
• All-trans Retinoic Acid (all-trans retinoic acid)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Myelogenous Leukaemia (AML), Myelodysplastic Syndrome (MDS) | Phase 2 | Status: COMPLETED